imusyn’s Post

Capsida’s Chakameh Azimpour, Ph.D will be presenting a poster at the 2024 PDA Advanced Therapy Medicinal Products Conference:   📅 Date: 24-25 June 2024 📍 Location: Amsterdam, The Netherlands   The poster, entitled "Development of a dual reporter cargo and systemic incorporation of a highly flexible, benchtop automation system to facilitate rAVV9 based novel capsid development and characterization," showcases innovative research that highlights the breadth of Capsida’s analytical development expertise in characterizing novel engineered capsids.   This work is a collaborative effort by a talented team of Capsida researchers: Paul Denis, Kevin Chu, Jesse Granados, Regan Sobaje, Claire S., Leandro Fernandez, Tiffany Morrison, Lysa-Anne Volpe, Chakameh Azimpour, Ph.D.   Well done to the whole team!   #AdvancedTherapies #PDAConference #CapsidDevelopment #BiotechInnovation #ScientificResearch #AutomationInScience #GeneTherapy #ATMP #AdvancedTherapyMedicinalProduct  

Interested in learning more about organoids? Join our webinar with our Field Application Scientist Idil Arioz for comprehensive insights in this field.

From tissue to cells - gentle and easy!

In case you missed it, our recent webinar with Kactus Bio is now available on-demand. Dr. Man-Hee Suh, Co-Founder & CTO at KACTUS, shares how they used Gator Biolayer Interferometry for binding kinetics studies on GPCR/VLP and GPCR nanodiscs. Watch it now: https://lnkd.in/gkjeyK65 #GatorBio #GatorBLI #BiolayerInterferometry #KactusBio #Kactus #GeneTherapy #AAVtiter #Webinar

The Solid-State Characterization team at Alcami Corporation possesses the specialized knowledge required to develop and implement crystal form screening processes, as well as to perform thorough assessments of new API forms. Their recent work includes a study that led to the identification of a new chiral version of the well-known medication, guaifenesin. This study, which involved detailed analysis and measurement, was featured in an article published by “Crystal Growth and Design,” entitled: “Discovery, Characterization, and Solid-State Quantification of the Racemic Compound of Guaifenesin.” Kudos to Joanna Bis, Briana Graves, Frank Tarczynski, and Lukasz Wojtas for their contribution to this significant publication! Explore the article here ➡️ https://gag.gl/oLTgQB #SolidStateCharacterization #Crystalformscreening #SolidStateQuantification #Discovery #casestudy #artinspiration #racemiccompound #smallmolecule #crystallization #CDMO #Alcami #research #APIscreening #published

The Solid-State Characterization team at Alcami Corporation possesses the specialized knowledge required to develop and implement crystal-form screening processes, as well as to conduct thorough assessments of new API forms. Their expertise was recently showcased in a study that not only identified a novel chiral modification of the well-established drug guaifenesin but also provided an in-depth analysis and quantification. This work has been featured in “Crystal Growth and Design,” under the title: “Discovery, Characterization, and Solid-State Quantification of the Racemic Compound of Guaifenesin.” A round of applause for Joanna Bis, Briana Graves, Frank Tarczynski, and Lukasz Wojtas for their contributions to this significant publication! Explore the article here ➡️ https://gag.gl/oLTgQB #SolidStateCharacterization #Crystalformscreening #SolidStateQuantification #Discovery #casestudy #artinspiration #racemiccompound #smallmolecule #crystallization #CDMO #Alcami #research #APIscreening #published

The Solid-State Characterization group at Alcami Corporation boasts the capability to craft and implement crystal-form screening processes, alongside thorough analysis of new API configurations. Their expertise was recently showcased in a study that unveiled a novel chiral version of the well-known medication, guaifenesin. This work involved extensive identification, detailed examination, and quantification efforts, culminating in a publication within “Crystal Growth and Design,” under the title: “Discovery, Characterization, and Solid-State Quantification of the Racemic Compound of Guaifenesin.” Kudos to Joanna Bis, Briana Graves, Frank Tarczynski, and Lukasz Wojtas for their contribution to this significant research! Explore the study here ➡️ https://gag.gl/oLTgQB #SolidStateCharacterization #Crystalformscreening #SolidStateQuantification #Discovery #casestudy #artinspiration #racemiccompound #smallmolecule #crystallization #CDMO #Alcami #research #APIscreening #published

Following recent news from Charles River Laboratories, regarding their continued investment into their Alternative Methods Advancement Project (AMAP), to reduce reliance on animal testing - we are thrilled to share a collaborative #genotoxicity publication between CRL, CN Bio and TwinStrand Biosciences. The publication demonstrates that Liver-on-a-chip is a promising tool for genotoxicity assessment. Click the link to learn more & congrats to all involved! #animalalternatives #organonchip #microphysiologicalsystem

Day 2 in CEPharm 2024 LA, we have a lunch and learn workshop with two topics and all is welcomed: 1.icIEF fractionation Using the AES CEInfinite Platform: Discover our work on separating mAb charge isoforms using the CEInfinite platform. This includes peak-based fractionation for dynamic, reproducible collection of peak profile components, which can be utilized for further analyses. 2.icIEF-MS Online Coupling Workflow: Learn about our icIEF-MS online coupling workflow with the CEInfinite platform, integrated directly with the Thermo Orbitrap Exploris 240. We will present an analysis of ADC (polatuzumab vedotin) charge variants under near-native conditions and demonstrate single-point control using Thermo’s Chromeleon software. #casss #cepharm #ce #biopharma #icIEF

Have you registered for the “Biomacromolecule Analysis by Multiple Modes of Chromatography” webinar, organized in cooperation with Tosoh Bioscience LLC? Sign up today so you don't miss out! The session goes live on November 5, 2024, at 10 AM EST (New York) / 3 PM BST (London) / 4 PM CEST (Paris/Berlin) / 8 PM IST (Mumbai) and focuses on key strategies and techniques to enhance resolution and efficiency for MS and MALS platforms. #BiomacromoleculeAnalysis